Phloretin inhibits transmissible gastroenteritis virus proliferation via multiple mechanisms
Journal of General Virology · 30.05.2024 · 105 (5)
DOI: 10.1099/jgv.0.001996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, erschienen am 30.05.2024. Verfasst von Yuting Duan und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China. Hauptthemen laut MEDLINE: Transmissible gastroenteritis virus, Phloretin, Virus Replication, Antiviral Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Transmissible gastroenteritis virus (TGEV), an enteropathogenic coronavirus, has caused huge economic losses to the pig industry, with 100% mortality in piglets aged 2 weeks and intestinal injury in pigs of other ages. However, there is still a shortage of safe and effective anti-TGEV drugs in clinics. In this study, phloretin, a naturally occurring dihydrochalcone glycoside, was identified as a potent antagonist of TGEV. Specifically, we found phloretin effectively inhibited TGEV proliferation in PK-15 cells, dose-dependently reducing the expression of TGEV N protein, mRNA, and virus titer. The anti-TGEV activity of phloretin was furthermore refined to target the internalization and replication stages. Moreover, we also found that phloretin could decrease the expression levels of proinflammatory cytokines induced by TGEV infection. In addition, we expanded the potential key targets associated with the anti-TGEV effect of phloretin to AR, CDK2, INS, ESR1, ESR2, EGFR, PGR, PPARG, PRKACA, and MAPK14 with the help of network pharmacology and molecular docking techniques. Furthermore, resistant viruses have been selected by culturing TGEV with increasing concentrations of phloretin. Resistance mutations were reproducibly mapped to the residue (S242) of main protease (M pro ). Molecular docking analysis showed that the mutation (S242F) significantly disrupted phloretin binding to M pro , suggesting M pro might be a potent target of phloretin. In summary, our findings indicate that phloretin is a promising drug candidate for combating TGEV, which may be helpful for developing pharmacotherapies for TGEV and other coronavirus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, PR China.
- Hubei Key Laboratory of Renal Disease Occurrence and Intervention, Medical School, Hubei Polytechnic University, Huangshi, PR China.
- College of Life Science and Technology, Wuhan University of Bioengineering, Wuhan, PR China.
- Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan, PR China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Duan, Y., Li, H., Huang, S., Li, Y., Chen, S., & Xie, L. (2024). Phloretin inhibits transmissible gastroenteritis virus proliferation via multiple mechanisms. Journal of General Virology, 105(5). https://doi.org/10.1099/jgv.0.001996
Vancouver
Duan Y, Li H, Huang S, Li Y, Chen S, Xie L. Phloretin inhibits transmissible gastroenteritis virus proliferation via multiple mechanisms. Journal of General Virology. 2024;105(5). doi:10.1099/jgv.0.001996
BibTeX
@article{Duan2024,
author = {Duan, Yuting and Li, Haichuan and Huang, Shuai and Li, Yaoming and Chen, Shuyi and Xie, Lilan},
title = {Phloretin inhibits transmissible gastroenteritis virus proliferation via multiple mechanisms},
journal = {Journal of General Virology},
year = {2024},
volume = {105},
number = {5},
doi = {10.1099/jgv.0.001996}
}
EUVIMED